drugset / Trial / NCT01833455
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of this study is to determine if reduction in premature ventricular contraction (PVC) burden results in a decrease in blood pressure, sympathetic outflow, plasma catecholamines and an improvement in baroreflex gain. Flecainide will be used for PVC suppression in a randomized, double-blinded, crossover fashion.
Timeline
- Start
- 2013-02
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | flecainide | Small molecule | — | — |